Last reviewed · How we verify
NCT06577623
In-Person Mindfulness-based Intervention for Adolescents With Autism Spectrum Disorder and Their Caregivers
NA trial testing MINDful TIME in Autism Spectrum Disorder in 28 participants. Completed in 30 January 2026.
30 January 2026
Quick facts
| Lead sponsor | Southwest Autism Research & Resource Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 28 |
| Start date | 14 August 2024 |
| Primary completion | 30 January 2026 |
| Estimated completion | 30 January 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- MINDful TIME
Conditions studied
- Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →
- Autism — all drugs for Autism →
Sponsor
Southwest Autism Research & Resource Center — full company profile →
Who can join
Adults 13 to 18, any sex, with Autism Spectrum Disorder or Autism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Adolescents with ASD often have co-occurring mental health symptoms like stress, anxiety, and depression. The investigators are conducting this research study to develop interventions for adolescents with ASD that will improve co-occurring mental health symptoms.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06577623
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of MINDful TIME
Trials testing the same drug.
- NCT05685589 — Mindfulness-Based Intervention for Teens With Autism Spectrum Disorder and Their Caregivers · NA · completed
Other recruiting trials for Autism Spectrum Disorder
Currently open trials in the same condition.
- NCT07324057 — The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavi · NA · recruiting
- NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
- NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
- NCT07524192 — A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Childre · NA · recruiting
- NCT07432776 — Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design · EARLY_PHASE1 · recruiting
Other Southwest Autism Research & Resource Center trials
Trials by the same sponsor.
- NCT06526208 — Investigating a Marijuana-based Compound as a Treatment for Anxiety in Autistic Adults · Phase 2 · recruiting
- NCT04322734 — Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders · recruiting
- NCT05685589 — Mindfulness-Based Intervention for Teens With Autism Spectrum Disorder and Their Caregivers · NA · completed
- NCT04802434 — Strengthening Skills Behavioral Intervention for Adults With Autism Spectrum Disorder · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06577623 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Southwest Autism Research & Resource Center
- Last refreshed: 30 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06577623.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing